Loading...

Intracellular Staining Permeabilization Wash Buffer (10X) Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  2. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  3. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  4. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  5. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  6. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  7. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  8. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  9. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  10. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  11. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  12. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  13. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  14. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  15. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  16. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  17. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  18. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  19. Chan L, et al. 2022. Cells. 12: . PubMed
  20. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  21. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  22. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  23. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  24. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  25. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  26. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  27. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  28. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  29. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  30. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  31. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  32. Kim S, et al. 2020. Development. 147:00:00. PubMed
  33. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  34. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  35. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  36. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  37. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  38. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  39. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  40. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  41. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  42. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  43. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  44. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  45. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  46. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  47. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  48. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  49. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  50. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  51. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  52. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  53. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  54. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  55. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  56. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  57. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  58. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  59. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  60. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  61. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  62. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  63. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  64. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  65. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  66. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  67. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  68. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  69. Poli V, et al. 2021. iScience. 24:103256. PubMed
  70. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  71. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  72. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  73. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  74. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  75. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  76. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  77. Stewart CA, et al. 2020. bioRxiv. . PubMed
  78. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  79. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  80. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  81. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  82. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  83. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  84. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  85. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  86. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  87. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  88. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  89. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  90. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  91. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  92. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  93. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  94. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  95. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  96. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  97. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  98. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  99. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  100. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  101. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  102. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  103. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  104. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  105. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  106. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  107. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  108. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  109. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  110. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  111. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  112. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  113. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  114. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  115. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  116. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  117. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  118. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  119. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  120. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  121. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  122. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  125. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  126. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  129. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  130. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  131. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  132. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  133. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  139. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  140. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  141. Kim S, et al. 2020. Development. . PubMed
  142. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  143. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  144. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  145. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  146. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  147. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  148. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  149. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  150. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  151. Ma K, et al. 2022. iScience. 25:104347. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  154. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  156. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  157. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  158. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  159. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  160. Lau H, et al. 2020. Islets. 41:12. PubMed
  161. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  162. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  163. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  164. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  165. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  166. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  167. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  168. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  169. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  170. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  171. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  172. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  173. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  174. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  175. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  176. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  177. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  178. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  179. Lee G, et al. 2021. Viruses. 13: . PubMed
  180. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  181. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  182. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  186. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  187. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  188. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  189. Su Y, et al. 2020. Cell. 1479:183. PubMed
  190. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  191. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  192. Wang X, et al. 2022. Elife. 11:. PubMed
  193. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  194. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  195. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  196. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  197. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  205. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  206. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  211. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  212. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  213. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  214. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  215. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  216. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  217. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  218. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  219. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  220. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  221. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  222. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  223. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  224. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  225. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  226. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  227. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  228. Chan L, et al. 2022. Cells. 12: . PubMed
  229. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  230. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  231. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  232. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  233. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  234. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  235. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  236. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  237. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  238. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  239. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  240. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  241. Kim S, et al. 2020. Development. 147:00:00. PubMed
  242. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  243. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  244. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  245. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  246. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  247. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  248. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  249. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  250. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  251. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  252. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  253. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  254. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  255. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  256. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  257. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  258. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  259. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  260. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  261. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  262. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  263. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  264. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  265. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  266. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  267. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  268. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  269. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  270. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  271. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  272. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  273. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  274. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  275. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  276. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  277. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  278. Poli V, et al. 2021. iScience. 24:103256. PubMed
  279. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  280. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  281. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  282. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  283. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  284. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  285. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  286. Stewart CA, et al. 2020. bioRxiv. . PubMed
  287. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  288. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  289. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  290. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  291. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  292. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  293. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  294. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  295. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  296. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  297. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  298. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  299. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  300. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  301. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  302. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  303. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  304. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  305. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  306. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  307. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  308. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  309. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  310. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  311. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  312. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  313. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  314. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  315. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  316. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  317. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  318. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  319. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  320. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  321. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  322. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  323. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  324. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  325. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  326. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  327. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  328. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  329. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  330. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  331. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  334. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  335. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  336. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  337. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  338. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  339. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  340. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  341. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  342. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  343. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  348. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  349. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  350. Kim S, et al. 2020. Development. . PubMed
  351. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  352. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  353. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  354. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  355. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  356. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  357. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  358. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  359. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  360. Ma K, et al. 2022. iScience. 25:104347. PubMed
  361. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  362. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  363. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  364. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  365. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  366. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  367. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  368. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  369. Lau H, et al. 2020. Islets. 41:12. PubMed
  370. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  371. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  372. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  373. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  374. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  375. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  376. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  377. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  378. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  379. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  380. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  381. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  382. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  383. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  384. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  385. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  386. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  387. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  388. Lee G, et al. 2021. Viruses. 13: . PubMed
  389. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  390. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  391. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  392. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  393. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  394. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  395. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  396. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  397. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  398. Su Y, et al. 2020. Cell. 1479:183. PubMed
  399. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  400. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  401. Wang X, et al. 2022. Elife. 11:. PubMed
  402. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  403. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  404. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  405. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  406. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  407. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  408. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  414. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  415. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  416. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  417. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  418. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  2. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  3. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  4. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  5. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  6. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  7. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  8. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  9. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  10. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  11. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  12. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  13. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  14. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  15. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  16. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  17. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  18. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  19. Chan L, et al. 2022. Cells. 12: . PubMed
  20. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  21. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  22. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  23. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  24. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  25. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  26. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  27. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  28. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  29. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  30. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  31. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  32. Kim S, et al. 2020. Development. 147:00:00. PubMed
  33. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  34. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  35. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  36. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  37. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  38. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  39. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  40. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  41. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  42. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  43. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  44. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  45. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  46. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  47. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  48. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  49. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  50. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  51. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  52. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  53. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  54. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  55. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  56. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  57. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  58. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  59. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  60. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  61. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  62. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  63. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  64. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  65. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  66. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  67. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  68. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  69. Poli V, et al. 2021. iScience. 24:103256. PubMed
  70. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  71. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  72. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  73. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  74. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  75. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  76. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  77. Stewart CA, et al. 2020. bioRxiv. . PubMed
  78. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  79. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  80. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  81. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  82. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  83. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  84. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  85. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  86. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  87. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  88. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  89. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  90. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  91. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  92. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  93. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  94. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  95. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  96. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  97. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  98. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  99. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  100. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  101. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  102. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  103. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  104. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  105. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  106. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  107. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  108. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  109. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  110. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  111. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  112. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  113. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  114. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  115. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  116. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  117. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  118. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  119. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  120. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  121. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  122. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  125. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  126. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  129. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  130. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  131. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  132. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  133. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  139. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  140. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  141. Kim S, et al. 2020. Development. . PubMed
  142. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  143. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  144. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  145. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  146. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  147. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  148. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  149. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  150. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  151. Ma K, et al. 2022. iScience. 25:104347. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  154. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  156. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  157. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  158. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  159. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  160. Lau H, et al. 2020. Islets. 41:12. PubMed
  161. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  162. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  163. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  164. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  165. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  166. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  167. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  168. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  169. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  170. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  171. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  172. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  173. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  174. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  175. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  176. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  177. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  178. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  179. Lee G, et al. 2021. Viruses. 13: . PubMed
  180. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  181. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  182. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  186. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  187. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  188. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  189. Su Y, et al. 2020. Cell. 1479:183. PubMed
  190. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  191. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  192. Wang X, et al. 2022. Elife. 11:. PubMed
  193. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  194. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  195. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  196. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  197. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  205. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  206. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  211. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  212. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  213. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  214. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  215. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  216. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  217. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  218. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  219. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  220. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  221. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  222. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  223. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  224. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  225. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  226. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  227. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  228. Chan L, et al. 2022. Cells. 12: . PubMed
  229. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  230. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  231. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  232. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  233. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  234. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  235. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  236. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  237. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  238. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  239. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  240. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  241. Kim S, et al. 2020. Development. 147:00:00. PubMed
  242. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  243. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  244. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  245. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  246. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  247. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  248. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  249. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  250. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  251. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  252. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  253. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  254. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  255. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  256. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  257. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  258. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  259. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  260. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  261. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  262. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  263. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  264. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  265. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  266. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  267. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  268. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  269. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  270. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  271. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  272. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  273. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  274. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  275. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  276. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  277. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  278. Poli V, et al. 2021. iScience. 24:103256. PubMed
  279. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  280. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  281. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  282. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  283. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  284. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  285. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  286. Stewart CA, et al. 2020. bioRxiv. . PubMed
  287. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  288. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  289. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  290. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  291. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  292. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  293. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  294. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  295. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  296. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  297. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  298. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  299. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  300. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  301. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  302. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  303. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  304. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  305. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  306. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  307. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  308. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  309. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  310. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  311. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  312. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  313. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  314. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  315. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  316. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  317. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  318. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  319. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  320. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  321. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  322. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  323. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  324. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  325. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  326. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  327. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  328. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  329. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  330. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  331. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  334. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  335. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  336. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  337. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  338. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  339. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  340. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  341. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  342. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  343. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  348. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  349. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  350. Kim S, et al. 2020. Development. . PubMed
  351. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  352. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  353. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  354. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  355. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  356. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  357. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  358. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  359. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  360. Ma K, et al. 2022. iScience. 25:104347. PubMed
  361. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  362. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  363. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  364. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  365. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  366. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  367. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  368. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  369. Lau H, et al. 2020. Islets. 41:12. PubMed
  370. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  371. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  372. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  373. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  374. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  375. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  376. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  377. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  378. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  379. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  380. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  381. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  382. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  383. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  384. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  385. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  386. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  387. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  388. Lee G, et al. 2021. Viruses. 13: . PubMed
  389. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  390. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  391. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  392. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  393. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  394. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  395. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  396. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  397. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  398. Su Y, et al. 2020. Cell. 1479:183. PubMed
  399. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  400. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  401. Wang X, et al. 2022. Elife. 11:. PubMed
  402. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  403. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  404. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  405. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  406. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  407. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  408. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  414. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  415. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  416. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  417. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  418. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account